Compared to the surrounding non-cancerous tissues, the vascular endothelial growth factor (VEGF) is upregulated in most solid cancers, including prostate cancer, and one of the major sources of VEGF in the TME is CAFs [113]. The gene discussed is VEGFA; the disease is Familial prostate cancer.